Please provide your email address to receive an email when new articles are posted on . Since May 2023, a combination of neuraminidase mutations has been detected in influenza A(H1N1)pdm09 viruses.

Randomized trial shows superiority in adults 50 and older ...

ATLANTA — Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant that enhances ...

Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus. Their study in mice sheds light on the unexplored “dark side” of the ...

Immune-priming events such as COVID-19 and influenza vaccinations may have cross-protective effects on the incidence of other viral ARIs.

ATLANTA — A novel vaccine platform has been developed to induce broad, protective immunity against numerous influenza virus infections, showing promise as an effective mucosal vaccine strategy, ...

September 5, 2012 — The outbreak of a novel swine influenza virus claimed its first life last week, even as it was slowing down across the country, according to the Centers for Disease Control and ...

CD388 is an investigational drug-Fc conjugate that combines zanamivir, a neuraminidase inhibitor, with a human antibody fragment. The Food and Drug Administration (FDA) has granted Breakthrough ...

A recent PLoS Pathogens study evaluates the efficacy of a newly developed live-attenuated influenza vaccine (LAIV) protocol in eliciting immune responses in a porcine animal model. Study: Evaluation ...

Research shows ferrets infected both with seasonal flu and with the novel H1N1 virus commonly called "swine flu" more readily transmitted the novel virus to other animals, the National Institutes of ...